Highly Differentiated, Resting Gn-Specific Memory CD8 T Cells Persist Years after Infection by Andes Hantavirus

English version České info

In man, infection with South American Andes virus (ANDV) causes hantavirus cardiopulmonary syndrome (HCPS). HCPS due to ANDV is endemic in Southern Chile and much of Argentina and increasing numbers of cases are reported all over South America. A case-fatality rate of about 36% together with the absence of successful antiviral therapies urge the development of a vaccine. Although T-cell responses were shown to be critically involved in immunity to hantaviruses in mouse models, no data are available on the magnitude, specificity and longevity of ANDV-specific memory T-cell responses in patients. Using sets of overlapping peptides in IFN-γ ELISPOT assays, we herein show in 78 Chilean convalescent patients that Gn-derived epitopes were immunodominant as compared to those from the N- and Gc-proteins. Furthermore, while the relative contribution of the N-specific response significantly declined over time, Gn-specific responses remained readily detectable ex vivo up to 13 years after the acute infection. Tetramer analysis further showed that up to 16.8% of all circulating CD3⁺CD8⁺ T cells were specific for the single HLA-B*3501-restricted epitope Gn_465–473 years after the acute infection. Remarkably, Gn_465–473–specific cells readily secreted IFN-γ, granzyme B and TNF-α but not IL-2 upon stimulation and showed a ‘revertant’ CD45RA⁺CD27⁻CD28⁻CCR7⁻CD127⁻ effector memory phenotype, thereby resembling a phenotype seen in other latent virus infections. Most intriguingly, titers of neutralizing antibodies increased over time in 10/17 individuals months to years after the acute infection and independently of whether they were residents of endemic areas or not. Thus, our data suggest intrinsic, latent antigenic stimulation of Gn-specific T-cells. However, it remains a major task for future studies to proof this hypothesis by determination of viral antigen in convalescent patients. Furthermore, it remains to be seen whether Gn-specific T cells are critical for viral control and protective immunity. If so, Gn-derived immunodominant epitopes could be of high value for future ANDV vaccines.

Vyšlo v časopise: Highly Differentiated, Resting Gn-Specific Memory CD8 T Cells Persist Years after Infection by Andes Hantavirus. PLoS Pathog 6(2): e32767. doi:10.1371/journal.ppat.1000779
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000779

Souhrn

Zdroje

1. BayardV

KitsutaniPT

BarriaEO

RuedasLA

TinninDS

2004 Outbreak of hantavirus pulmonary syndrome, Los Santos, Panama, 1999–2000. Emerg Infect Dis 10 1635 1642

2. MattarS

ParraM

2004 Serologic evidence of hantavirus infection in humans, Colombia. Emerg Infect Dis 10 2263 2264

3. ToroJ

VegaJD

KhanAS

MillsJN

PadulaP

1998 An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg Infect Dis 4 687 694

4. WeissenbacherMC

CuraE

SeguraEL

HortalM

BaekLJ

1996 Serological evidence of human Hantavirus infection in Argentina, Bolivia and Uruguay. Medicina (B Aires) 56 17 22

5. da SilvaMV

VasconcelosMJ

HidalgoNT

VeigaAP

CanzianM

1997 Hantavirus pulmonary syndrome. Report of the first three cases in Sao Paulo, Brazil. Rev Inst Med Trop Sao Paulo 39 231 234

6. Chile MdSd 2009 El vigía 20. http://epi.minsal.cl/epi/html/frames/frame1.htm

7. VialPA

ValdiviesoF

MertzG

CastilloC

BelmarE

2006 Incubation period of hantavirus cardiopulmonary syndrome. Emerg Infect Dis 12 1271 1273

8. NIAID 2009 List of NIAID Emerging and Re-emerging Diseases. http://www3.niaid.nih.gov/topics/emerging/list.htm

9. PadulaPJ

EdelsteinA

MiguelSD

LopezNM

RossiCM

1998 Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 241 323 330

10. MartinezVP

BellomoC

San JuanJ

PinnaD

ForlenzaR

2005 Person-to-person transmission of Andes virus. Emerg Infect Dis 11 1848 1853

11. FerresM

VialP

MarcoC

YanezL

GodoyP

2007 Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in chile. J Infect Dis 195 1563 1571

12. SchmaljohnC

HjelleB

1997 Hantaviruses: a global disease problem. Emerg Infect Dis 3 95 104

13. KilpatrickED

TerajimaM

KosterFT

CatalinaMD

CruzJ

2004 Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J Immunol 172 3297 3304

14. KosterF

VigilJ

OlsonD

TerajimaM

EnnisF

2001 Class I, II and III HLA alleles associated with severe hantavirus cardiopulmonary syndrome in the southwest US. Am J Trop Med 65 (Abstr.)

15. NakamuraT

YanagiharaR

GibbsCJJr

GajdusekDC

1985 Immune spleen cell-mediated protection against fatal Hantaan virus infection in infant mice. J Infect Dis 151 691 697

16. NakamuraT

YanagiharaR

GibbsCJJr

AmyxHL

GajdusekDC

1985 Differential susceptibility and resistance of immunocompetent and immunodeficient mice to fatal Hantaan virus infection. Arch Virol 86 109 120

17. AsadaH

TamuraM

KondoK

DohiY

YamanishiK

1988 Cell-mediated immunity to virus causing haemorrhagic fever with renal syndrome: generation of cytotoxic T lymphocytes. J Gen Virol 69 2179 2188

18. ArakiK

YoshimatsuK

LeeBH

KariwaH

TakashimaI

2003 Hantavirus-specific CD8(+)-T-cell responses in newborn mice persistently infected with Hantaan virus. J Virol 77 8408 8417

19. WooGJ

ChunEY

KimKH

KimW

2005 Analysis of immune responses against nucleocapsid protein of the Hantaan virus elicited by virus infection or DNA vaccination. J Microbiol 43 537 545

20. de Carvalho NicacioC

Gonzalez Della ValleM

PadulaP

BjorlingE

PlyusninA

2002 Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses. J Virol 76 6669 6677

21. Padula June 13–15, 2007 Pathogenic Aspects and Protective Immune Response of Andes Hantavirus. VII International Conference on HFRS, HPS and Hantavirus.

22. SafronetzD

HegdeNR

EbiharaH

DentonM

KobingerGP

2009 Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus. J Virol 83 7285 7295

23. ManigoldT

MartinezJ

LazcanoX

YeC

SchwartzS

2008 Case report: T-cell responses during clearance of Andes virus from blood cells 2 months after severe hantavirus cardiopulmonary syndrome. J Med Virol 80 1947 1951

24. Van EppsHL

SchmaljohnCS

EnnisFA

1999 Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein. J Virol 73 5301 5308

25. Van EppsHL

TerajimaM

MustonenJ

ArstilaTP

CoreyEA

2002 Long-lived memory T lymphocyte responses after hantavirus infection. J Exp Med 196 579 588

26. LeeKY

ChunE

KimNY

SeongBL

2002 Characterization of HLA-A2.1-restricted epitopes, conserved in both Hantaan and Sin Nombre viruses, in Hantaan virus-infected patients. J Gen Virol 83 1131 1136

27. EnnisFA

CruzJ

SpiropoulouCF

WaiteD

PetersCJ

1997 Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness. Virology 238 380 390

28. TuuminenT

KekalainenE

MakelaS

Ala-HouhalaI

EnnisFA

2007 Human CD8+ T cell memory generation in Puumala hantavirus infection occurs after the acute phase and is associated with boosting of EBV-specific CD8+ memory T cells. J Immunol 179 1988 1995

29. HjelleB

2002 Vaccines against hantaviruses. Expert Rev Vaccines 1 373 384

30. MeissnerJD

RoweJE

BoruckiMK

St JeorSC

2002 Complete nucleotide sequence of a Chilean hantavirus. Virus Res 89 131 143

31. HammarlundE

LewisMW

HansenSG

StrelowLI

NelsonJA

2003 Duration of antiviral immunity after smallpox vaccination. Nat Med 9 1131 1137

32. BurrowsSR

GardnerJ

KhannaR

StewardT

MossDJ

1994 Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3. J Gen Virol 75 (Pt 9) 2489 2493

33. BoonAC

de MutsertG

GrausYM

FouchierRA

SintnicolaasK

2002 Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. J Virol 76 2567 2572

34. KleinMR

HammondAS

SmithSM

JayeA

LukeyPT

2002 HLA-B*35-restricted CD8(+)-T-cell epitope in Mycobacterium tuberculosis Rv2903c. Infect Immun 70 981 984

35. GoepfertPA

BansalA

EdwardsBH

RitterGDJr

TellezI

2000 A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon. J Virol 74 10249 10255

36. van LeeuwenEM

de BreeGJ

RemmerswaalEB

YongSL

TesselaarK

2005 IL-7 receptor alpha chain expression distinguishes functional subsets of virus-specific human CD8+ T cells. Blood 106 2091 2098

37. AppayV

DunbarPR

CallanM

KlenermanP

GillespieGM

2002 Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8 379 385

38. LiangM

MahlerM

KochJ

JiY

LiD

2003 Generation of an HFRS patient-derived neutralizing recombinant antibody to Hantaan virus G1 protein and definition of the neutralizing domain. J Med Virol 69 99 107

39. DantasJRJr

OkunoY

AsadaH

TamuraM

TakahashiM

1986 Characterization of glycoproteins of viruses causing hemorrhagic fever with renal syndrome (HFRS) using monoclonal antibodies. Virology 151 379 384

40. KochJ

LiangM

QueitschI

KrausAA

BautzEK

2003 Human recombinant neutralizing antibodies against hantaan virus G2 protein. Virology 308 64 73

41. HooperJW

CusterDM

SmithJ

Wahl-JensenV

2006 Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates. Virology 347 208 216

42. HooperJW

CusterDM

ThompsonE

SchmaljohnCS

2001 DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys. J Virol 75 8469 8477

43. CusterDM

ThompsonE

SchmaljohnCS

KsiazekTG

HooperJW

2003 Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. J Virol 77 9894 9905

44. McClainDJ

SummersPL

HarrisonSA

SchmaljohnAL

SchmaljohnCS

2000 Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine. J Med Virol 60 77 85

45. DongGM

HanL

AnQ

LiuWX

KongY

2005 Immunization effect of purified bivalent vaccine to haemorrhagic fever with renal syndrome manufactured from primary cultured hamster kidney cells. Chin Med J (Engl) 118 766 768

46. de Carvalho NicacioC

SallbergM

HultgrenC

LundkvistA

2001 T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: identification of T-helper epitopes in a mouse model. J Gen Virol 82 129 138

47. ParkJM

ChoSY

HwangYK

UmSH

KimWJ

2000 Identification of H-2K(b)-restricted T-cell epitopes within the nucleocapsid protein of Hantaan virus and establishment of cytotoxic T-cell clones. J Med Virol 60 189 199

48. WangM

WangJ

ZhuY

XuZ

YangK

2009 Cellular immune response to Hantaan virus nucleocapsid protein in the acute phase of hemorrhagic fever with renal syndrome: correlation with disease severity. J Infect Dis 199 188 195

49. AlffPJ

SenN

GorbunovaE

GavrilovskayaIN

MackowER

2008 The NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1-TRAF3 complex formation. J Virol 82 9115 9122

50. AlffPJ

GavrilovskayaIN

GorbunovaE

EndrissK

ChongY

2006 The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J Virol 80 9676 9686

51. SenN

SenA

MackowER

2007 Degrons at the C terminus of the pathogenic but not the nonpathogenic hantavirus G1 tail direct proteasomal degradation. J Virol 81 4323 4330

52. FerrerCP

VialPA

FerresM

GodoyP

CuizaA

2007 Genetic susceptibility to Andes Hantavirus: Association between severity of disease and HLA alieles in Chilean patients. Revista Chilena de Infectologia 24 351 359

53. KaechSM

WherryEJ

AhmedR

2002 Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2 251 262

54. BannardO

KramanM

FearonDT

2009 Secondary replicative function of CD8+ T cells that had developed an effector phenotype. Science 323 505 509

55. ThimmeR

AppayV

KoschellaM

PantherE

RothE

2005 Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation. J Virol 79 12112 12116

56. PaiardiniM

CervasiB

AlbrechtH

MuthukumarA

DunhamR

2005 Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. J Immunol 174 2900 2909

57. BengschB

SpangenbergHC

KerstingN

Neumann-HaefelinC

PantherE

2007 Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver. J Virol 81 945 953

58. OchsenbeinAF

PinschewerDD

SierroS

HorvathE

HengartnerH

2000 Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs. Proc Natl Acad Sci U S A 97 13263 13268

59. PinschewerDD

PerezM

JeetendraE

BachiT

HorvathE

2004 Kinetics of protective antibodies are determined by the viral surface antigen. J Clin Invest 114 988 993

60. ElyKH

AhmedM

KohlmeierJE

RobertsAD

WittmerST

2007 Antigen-specific CD8+ T cell clonal expansions develop from memory T cell pools established by acute respiratory virus infections. J Immunol 179 3535 3542

61. MarshS

ParhamP

BarberL

2000 The HLA Facts book. 398

62. PadulaPJ

RossiCM

Della ValleMO

MartinezPV

ColavecchiaSB

2000 Development and evaluation of a solid-phase enzyme immunoassay based on Andes hantavirus recombinant nucleoprotein. J Med Microbiol 49 149 155

63. RossiC, KT

1999 Enzyme-linked immunosorbent assay (ELISA)

LeeHW, CC

SchmaljohnCS

Manual of Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome Seoul WHO Collaborating Center for Virus Reference and Research 87 91

64. FeldmannH

SanchezA

MorzunovS

SpiropoulouCF

RollinPE

1993 Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res 30 351 367

65. GalenoH

MoraJ

VillagraE

FernandezJ

HernandezJ

2002 First human isolate of Hantavirus (Andes virus) in the Americas. Emerg Infect Dis 8 657 661

66. BharadwajM

NofchisseyR

GoadeD

KosterF

HjelleB

2000 Humoral immune responses in the hantavirus cardiopulmonary syndrome. J Infect Dis 182 43 48